ArticlePloS one2026
Association between obesity and medical expenditures among Japanese adults treated for diabetes: A secondary analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Japan, where obesity prevalence is lower than in Western countries, few studies have examined the association between obesity and medical expenditures among patients with diabetes, distinguishing between overweight and obesity by sex. This study examined the association between obesity and medical expenditures among patients with diabetes in Japan. Data on medical expenditures and the Specific Health Checkups obtained from 12 municipal and six union insurers for fiscal years 2008 and 2009 were analyzed. Gamma regression and quantile regression were used to compare annual total, outpatient, and inpatient medical expenditures in fiscal year 2009 among three groups: normal/underweight (body mass index [BMI] < 25 kg/m2), overweight (BMI: 25-30 kg/m2), and obesity (BMI ≥ 30 kg/m2). The analyses were performed separately for men and women, adjusting for age, hypertension, hyper-low-density lipoprotein cholesterolemia, glycemic control, and smoking. Logistic regression was performed, adjusting for the same variables to assess the occurrence of annual total medical expenditures of ¥1 million (approximately US$10,600 in 2009) or more. Annual total medical expenditures were significantly higher in the obesity group than in the normal/underweight group among both men and women (exp(β) = 1.117 [95% confidence interval (CI): 1.023-1.221] among men and exp(β) = 1.157 [1.036-1.295] among women). Both men and women in the overweight and obesity groups had significantly higher outpatient expenditures than those in the normal/underweight group. The overweight and obesity groups had significantly higher medical expenditures than the normal/underweight group in most quantiles among men. The likelihood of annual total medical expenditures exceeding ¥1 million was higher among women with obesity than among those with normal/underweight (odds ratio = 1.546 [95% CI: 1.007-2.375], p = 0.047). These findings suggest that medical expenditures among patients with diabetes who have overweight or obesity are higher than those of normal/underweight patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.